Skip to Content

C 431 (Darifenacin Hydrobromide Extended-Release 7.5 mg)

Pill with imprint C 431 is White, Round and has been identified as Darifenacin Hydrobromide Extended-Release 7.5 mg. It is supplied by Cipla USA Inc..

Darifenacin is used in the treatment of overactive bladder; urinary frequency; urinary incontinence and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Darifenacin 7.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for C 431

Darifenacin hydrobromide extended-release 7.5 mg C 431

Darifenacin Hydrobromide Extended-Release

Imprint
C 431
Strength
7.5 mg
Color
White
Size
8.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Urinary antispasmodics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Cipla USA Inc.
National Drug Code (NDC)
69097-0431
Inactive Ingredients
calcium phosphate dibasic anhydrous, hypromellose 2910 (3 mPa.s), magnesium stearate, magnesium silicate, titanium dioxide, polyethylene glycol 4000

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "C 431"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.